Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS - No Study Results Posted

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS (STAR)

This study is ongoing, but not recruiting participants.

Study NCT00573443 Information provided by Avanir Pharmaceuticals

First Received: December 13, 2007 Last Updated: May 3, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2009
Estimated Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)